Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

4.6K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
4.6K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

1.2K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.2K
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

15.3K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
15.3K
Chemical Synapses01:26

Chemical Synapses

7.6K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
7.6K
Chemical Synapses01:26

Chemical Synapses

12.3K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.3K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.1K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictive population balance modeling of pharmaceutical tablet disintegration and dissolution behavior.

International journal of pharmaceutics·2026
Same author

Unmasking counterfeit semaglutide: analysis of real-world safety data from EudraVigilance.

Frontiers in pharmacology·2026
Same author

Early Postoperative Outcomes with the Toumai<sup>®</sup> Surgical System for Robot-Assisted Radical Prostatectomy: A Prospective Comparative Study with da Vinci<sup>®</sup>.

Cancers·2026
Same author

Retroperitoneal robotic partial nephrectomy with the Versius system: a case series.

Minerva urology and nephrology·2026
Same author

Partial versus radical nephrectomy for pT3a renal cell carcinoma: a systematic review and meta-analysis.

Journal of robotic surgery·2026
Same author

Gut microbiome impact on systemic therapy outcomes in metastatic renal cell carcinoma: a systematic review.

World journal of urology·2026

Related Experiment Video

Updated: Mar 19, 2026

Microtransplantation of Synaptic Membranes to Reactivate Human Synaptic Receptors for Functional Studies
10:08

Microtransplantation of Synaptic Membranes to Reactivate Human Synaptic Receptors for Functional Studies

Published on: July 20, 2022

2.5K

Metabotropic Glutamate Receptor 7: From Synaptic Function to Therapeutic Implications.

Enza Palazzo1, Ida Marabese, Vito de Novellis

  • 1Department of Anesthesiology, Surgery and Emergency, The Second University of Naples, Piazza Luigi Miraglia 2, 80138 Naples, Italy. enza.palazzo@unina2.it.

Current Neuropharmacology
|June 17, 2016
PubMed
Summary

Metabotropic glutamate receptor 7 (mGluR7) plays a key role in central nervous system function. New negative allosteric modulators are vital for understanding mGluR7

More Related Videos

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
04:48

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate

Published on: July 10, 2018

9.8K
Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
10:46

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models

Published on: May 3, 2017

11.8K

Related Experiment Videos

Last Updated: Mar 19, 2026

Microtransplantation of Synaptic Membranes to Reactivate Human Synaptic Receptors for Functional Studies
10:08

Microtransplantation of Synaptic Membranes to Reactivate Human Synaptic Receptors for Functional Studies

Published on: July 20, 2022

2.5K
A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
04:48

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate

Published on: July 10, 2018

9.8K
Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
10:46

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models

Published on: May 3, 2017

11.8K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Metabotropic glutamate receptor 7 (mGluR7) is a presynaptic receptor with a crucial role in excitatory synapse regulation.
  • Its widespread distribution and conservation suggest a primary function in the central nervous system (CNS).
  • Dysregulation of mGluR7 is implicated in neurological and psychiatric disorders.

Purpose of the Study:

  • To review the role of mGluR7 in modulating synaptic function.
  • To discuss its involvement in normal CNS function and in disease models.
  • To highlight the importance of novel mGluR7 modulators for therapeutic development.

Main Methods:

  • Review of existing literature on mGluR7 function.
  • Analysis of studies using knockout mice and gene silencing.
  • Evaluation of findings from selective mGluR7 ligands, including agonists and negative allosteric modulators (NAMs).

Main Results:

  • mGluR7 modulates emotionality, stress, and fear responses.
  • Early agonists like AMN082 showed limitations in confirming knockout phenotypes due to rapid internalization and selectivity issues.
  • mGluR7 NAMs are essential for further research and therapeutic targeting.

Conclusions:

  • mGluR7 is a significant target for understanding and treating CNS disorders.
  • Selective mGluR7 NAMs offer a promising avenue for future research and drug development.
  • Further investigation into mGluR7's precise mechanisms is needed to fully exploit its therapeutic potential.